前位置: 主页 > 沈阳在线 > 新闻资讯 > 正文

南亚的孟加拉却领先其邻国率先仿制并且上市了

来源: 未知  2016-07-22 沈阳在线
    阿斯利康的新药AZD9291塔格瑞斯(Osimertinib)是一种口服的小分子第三代表皮生长因子酪氨酸激酶抑制剂(EGFR-TKI)。
    对于易瑞沙、特罗凯、凯美纳已经耐药的晚期非小细胞肺癌患者,AZD9291塔格瑞斯(Osimertinib)无疑是最好的选择。
    可是AZD929原研产品十多万元一疗程的价格成了发展中国家患者追求治疗的最大障碍。所以很多患者把希望寄托于仿制药大国印度的强行仿制。
http://www.dbdaily.net/201607/22114380.html
http://www.zjrxw.net/201607/22114381.html
http://www.zndaily.com/201607/22114382.html
http://www.zj126.com/201607/22114383.html
http://www.qhdushi.com/201607/22114384.html
http://www.yndushi.com/201607/22114385.html
http://www.lndushi.com/article/201622114386.html
http://www.hljdushi.com/article/201622114387.html
http://www.gsdushi.com/article/201622114388.html
http://www.jldushi.com/article/201622114389.html
http://www.gddushi.com/article/201622114390.html
http://www.on1ne.com/article/201622114391.html
http://www.teixun.com/article/201622114392.html
http://www.js404.cn/article/201622114393.html
http://www.onlne.cn/article/201622114394.html
http://www.chLna.cn/article/201622114395.html
http://www.shdushi.net/201607/22114396.html
http://www.hn126.net/201607/22114397.html
http://www.laicaiw.com/html/201607/22114398.html
http://www.5caiw.com/html/201607/22114399.html
http://www.9cjw.com/html/201607/22114400.html
http://www.yicaiw.cn/article/201607/22114401.html
http://www.ofinance.cn/article/201607/22114402.html
http://www.fjvnet.cn/article/201607/22114403.html
http://www.lnrxw.cn/article/201607/22114404.html
http://www.jlrxw.cn/article/201607/22114405.html
http://www.1nfo.cn/article/201607/22114406.html
http://www.bjvnet.net/201607/22114407.html
http://www.xbdaily.net/201607/22114408.html
http://www.hddaily.net/article/201607/22114409.html
http://www.xnnews.net/article/201607/22114410.html
http://www.nfinfo.cn/article/201607/22114411.html
http://www.sunews.cn/article/201607/22114412.html
http://www.shanghai.mpnews.cn/html/201607/22120558.html
http://www.peixun.medicinal.cn/2016/0722120559.html
http://www.tjqc.qieche.cn/html/201607120560.html
http://www.fujian.mpnews.cn/xinwen/201607/22120561.html
http://www.guizhou.mpnews.cn/news/201607/22120562.html
http://www.haoyou.zeiyou.cn/201607/12056322.html
http://www.shenzhenw.kjnews.com.cn/news/201622120564.html
http://www.hnit.kjnews.com.cn/article/201607/22120565.html
http://www.sjnews.queren.cn/xinwen/201622120566.html
http://www.qinghaikj.kjnews.com.cn/article/201622120567.shtml
http://www.guangdong.mpnews.cn/news/201607/22120568.htm
http://www.sxshuma.kjnews.com.cn/201607/22120569.htm
http://www.guangxi.mpnews.cn/news/201622120570.htm
http://www.shqc.qieche.cn/article/201607/22120571.htm
http://www.yyqy.medicinal.cn/xinwen/201607/22120572.htm
http://www.meiyou.liayou.cn/201607/22120573.html
http://www.kbol.kanbu.cn/xinwen/201622120574.htm
http://www.hunanit.kjnews.com.cn/201607/22120575.shtml
http://www.caixun.maigei.cn/html/201607/22120576.shtml
http://www.jzqc.qieche.cn/article/201622120577.html
http://www.bjqc.qieche.cn/html/201607/22120578.shtml
http://www.qiyec.jueche.cn/article/201607/22120579.shtml
http://www.news.kjnews.com.cn/2016/0722120580.shtml
http://www.fujians.kjnews.com.cn/article/201607/22120581.html
http://www.gsit.kjnews.com.cn/news/201622120582.shtml
http://www.shandongw.kjnews.com.cn/news/201607/22120583.shtml
http://www.sichuanw.kjnews.com.cn/article/201622120584.shtml
http://www.hebeiit.kjnews.com.cn/201607/12058522.shtml
http://www.zjit.kjnews.com.cn/xinwen/201622120586.shtml
http://www.henanit.kjnews.com.cn/xinwen/201607/22120587.shtml
http://www.beijingw.kjnews.com.cn/html/201607120588.shtml
http://www.zhejiangw.kjnews.com.cn/article/201622120589.html
http://www.danews.liayou.cn/201607/22120590.shtml
http://www.henan.mpnews.cn/xinwen/201607/22120591.shtml
http://www.jiangxi.mpnews.cn/201607/22120592.html
http://www.shouji.acnews.cn/article/201622120593.html
http://www.paiming.mpnews.cn/news/201622120594.shtml
http://www.youxi.zeiyou.cn/201607/12059522.shtml
http://www.kanwen.kanbu.cn/news/201607/22120596.shtml
http://www.kanxun.kanbu.cn/2016/0722120597.shtml
http://www.jkol.jknews.cn/xinwen/201622120598.shtml
http://www.shkj.kjnews.com.cn/html/201607120599.html
http://www.zhongyou.zeiyou.cn/news/201607/22120600.html
http://www.kuai.liayou.cn/html/201607/22120601.htm
http://www.jingcai.queren.cn/xinwen/201607/22120602.html
http://www.qiye.maigei.cn/article/201607/22120603.htm
http://www.newsol.kjnews.com.cn/201607/12060422.html
http://www.hnpp.mpnews.cn/201607/22120605.htm
http://www.peixun.kjnews.com.cn/html/201607/22120606.html
http://www.jxzc.zjvnet.com/2016/0722120607.shtml
http://www.shenzhen.mpnews.cn/article/201622120608.htm
http://www.qyzs.kanbu.cn/news/201622120609.shtml
http://www.dayao.medicinal.cn/xinwen/201622120610.html
http://www.jueshi.jueche.cn/article/201622120611.htm
http://www.nmit.kjnews.com.cn/2016/0722120612.shtml
http://www.hubeiit.kjnews.com.cn/xinwen/201607/22120613.htm
http://www.kejipd.acnews.cn/html/201607120614.htm
http://www.nvren.jknews.cn/xinwen/201622120615.htm
http://www.zhejiang.mpnews.cn/html/201607120616.htm
http://www.nmpp.mpnews.cn/article/201607/22120617.shtml
http://www.dazj.jueche.cn/201607/12061822.htm
http://www.yypp.medicinal.cn/news/201607/22120619.htm
http://www.youle.liayou.cn/201607/12062022.htm
http://www.sichuan.mpnews.cn/201607/22120621.shtml
http://www.diannao.acnews.cn/2016/0722120622.htm
http://www.shouyou.zeiyou.cn/html/201607/22120623.htm
http://www.xinxi.zjvnet.com/html/201607120624.htm
http://www.dakang.jknews.cn/xinwen/201622120625.htm
http://www.zuixinzx.queren.cn/html/201607/22120626.shtml
http://www.caibian.queren.cn/article/201607/22120627.shtml
http://www.shuma.acnews.cn/201607/12062822.shtml
http://www.guangxiit.kjnews.com.cn/201607/12062922.htm
    然而这次同在南亚的孟加拉却领先其邻国率先仿制并且上市了AZD9291。
 
    小白海外医疗咨询公司在南亚,东南亚拥有丰富的医疗资源网络,可以协助您以最低的价格赴孟加拉购买正品药品。 我们提供签证、酒店、医院、一站式服务,让您以最快的速度,最低的价格,获得最好的治疗。

[责任编辑:]

网友评论:

已有1条评论

验证码: